Background The 69th World Health Assembly approved the Global Health Sector Strategy
to eliminate hepatitis C virus (HCV) infection by 2030, which can become a reality with the …

Background Since the release of the first global hepatitis elimination targets in 2016, and until
the COVID-19 pandemic started in early 2020, many countries and territories were making …

Since their discovery in the early 1960s, the quinolone group of antibacterials has generated
considerable clinical and scientific interest. Nalidixic acid, the first quinolone to be …

Background: Laboratory diagnosis of SARS-CoV-2 infection (the cause of COVID-19) uses
PCR to detect viral RNA (vRNA) in respiratory samples. SARS-CoV-2 RNA has also been …

Background A previous efficacy trial found benefit from inhaled budesonide for COVID-19 in
patients not admitted to hospital, but effectiveness in high-risk individuals is unknown. We …

We describe a gonorrhoea case with combined high-level azithromycin resistance and
ceftriaxone resistance. In February 2018, a heterosexual male was diagnosed with gonorrhoea in …

Background: The COVID-19 pandemic caused> 1 million infections during January-March
2020. There is an urgent need for reliable antibody detection approaches to support diagnosis…

Background The SARS-CoV-2 pandemic caused >1 million infections during January-March
2020. There is an urgent need for robust antibody detection approaches to support …

What few people thought possible little more than a decade ago is now reality: scientific and
operational advances are greatly reducing the number of deaths from HIV. The number of …

… Monique I Andersson reports grants from Prenetics and Pfizer, and personal fees from
Prenetics, outside the submitted work. Christopher C Butler and FD Richard Hobbs report grants …